Antigen-coupled antigen-presenting cells (APC) serve as potent tolerogens for inhibiting immune responses in vivo and in vitro, apparently by providing an antigen-specific signal through the TCR in the absence of co-stimulation. Although this approach has been well studied in rodents, little is known about its effects on human T cells. We evaluated the specificity and mechanisms of tolerization of human T cells in vitro using monocyte-enriched adherent cells that were pulsed with antigen and treated with the cross-linker, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (ECDI). Autologous antigen-coupled APC selectively tolerized T cells of the T h 1 but not T h 2 lineage through a mechanism that involved both antigen-specific and antigen-non-specific elements. The tolerization process was dependent on the ECDI and antigen concentration, and the coupling time, and was reflected by initial up-regulation of CD25. However, upon re-stimulation with fresh APC and antigen, tolerized T h 1 cells failed to proliferate or to produce T h 1 cytokine message or secreted protein, had decreased expression of CD25, CD28 and B7 and increased expression of MHC class II molecules, and demonstrated an enhanced commitment to apoptosis. T h 1 cell tolerization could be prevented by adding anti-CD28 antibody, IL-2 or untreated APC at the same time as the ECDI/ antigen-coupled APC, or reversed by adding anti-CD28 antibody or IL-2 upon re-stimulation with fresh APC plus antigen. Thus, the tolerizing effect of ECDI/antigen-coupled APC on human T h 1 cells appears to involve a reversible anergy mechanism leading to apoptosis, whereby the targeted T cells receive full or partial activation through the TCR, without coordinate co-stimulation. These data suggest dichotomous signaling requirements for inactivating cells of the T h 1 and T h 2 lineages that may have important implications for treatment of T h 1-mediated autoimmune or inflammatory diseases.
Introduction
Induction and resolution of inflammatory T cell responses well understood. Peripheral tolerance may be induced by systemic administration of antigen and may involve anergy requires activation and amplification of effector cells, and their selective termination through anergy and apoptosis (5-6) or deletional mechanisms including activation-induced cell death/apoptosis (AICD/AIA) mediated by engagement of (1-4). Although events that induce antigen-specific T cell activation have been well characterized, cellular interactions Fas or tumor necrosis receptors by their ligands (7-10). An additional tolerogenic approach to be explored here is leading to antigen-specific tolerance and deletion are less incubation of T cells with antigen presenting cells (APC) that gifts from Dr G. A. Hashim (New York, NY). The peptide corresponding to the TCR BV5S2-38-58 sequence was synhave been pulsed with antigen and chemically cross-linked using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (ECDI) thesized and purified by HPLC at the Portland VA Medical Center (24). HSV antigen was obtained from Whittaker MA (11) . Previous studies in rats and mice demonstrated that splenic (SPL) APC coupled with crude central nervous system Bioproducts, (Walkersville, MD) and TT from Wyeth Laboratories (Marietta, GA). TT peptides, T1 and T6, corresponding tissue extracts or purified encephalitogenic proteins and peptides could inhibit induction of experimental encephalomyto residues 591-602 (T1) and 952-967 (T6), were a kind gift of Dr Michael Davey (Portland VA Medical Center). elitis, antigen-specific T cell proliferation and T h 1-derived cytokine production (12) (13) (14) (15) (16) (17) (18) . Similarly, tolerance induced with
Antigen-specific T cell clones syngeneic splenocytes coupled to the peripheral nerve myelin P2 protein or a synthetic peptide could inhibit experimental Antigen-specific T cell clones were selected from peripheral blood mononuclear cells (PBMC). PBMC were separated by neuritis (19) (20) .
Tolerance induced by antigen-SPL is antigen dose dependa Ficoll-density centrifugation and cultured in medium (RPMI 1640 with 2% human pooled AB serum, 2 mM L-glutamine, ent and is exquisitely specific for the antigen used in the coupling step (15) (16) . In rodents, the mechanism of inhibition 1 mM sodium pyruvate, 100 µg/ml penicillin G and 100 µg/ml streptomycin) at 100,000 cells/well in 96-well round-bottomed appears to involve both inhibition and deletion of pathogenic T h 1 cells (i) by specific inactivation (i.e. anergy/apoptosis) or plates (Falcon, Becton Dickinson, Lincoln Park, NJ) in the presence of MBP (50 µg/ml), HSV (1/400 dilution) or TT (ii) by stimulation of T h 2 cells that may release regulatory cytokines including IL-4 and IL-10 (21). Specific inactivation
(1/200 dilution) or BV5S2-38-58 peptide (50 µg/ml) for 7 days at 37C and 5% CO 2 . At the end of the 7-day culture, the cells could involve MHC/antigen presentation in the absence of functional co-stimulatory molecules (i.e. B7-1/2 interaction were re-stimulated with antigen presented by autologous irradiated (2500 rad) PBMC (150,000/well). After 3 days, the with CTLA-4/CD28) that may be altered by the ECDI treatment, in accordance with an anergy model (5-6). Recent studies in reactivated T cells were expanded with 5 ng/ml recombinant (rh)IL-2 (R & D Systems, Minneapolis, MN) for an additional the Theiler's murine encephalitis virus model indicate that tolerance induced with virus-coupled splenocytes not only 4-7 days. T cells were selected and pooled from 10 of the best growing wells to make T cell lines or were further selected inhibited T h 1 responses, but also promoted T h 2 responses (22) and we observed a similar 'split tolerance' effect in the into antigen-specific clones by limiting dilution as described previously (26) . The clonality of selected T cell clones was Lewis rat experimental autoimmune encephalomyelitis (EAE) model (17) . The possible expansion of regulatory T h 2 cells demonstrated by response to a single epitope and predominant expression of a single TCR BV gene as detected by PCR. may account for earlier reports in which splenocytes transferred from ECDI/antigen-tolerized rats could suppress EAE T cell proliferation assay in naive recipients (12) (13) (14) .
Despite the extensive insights regarding tolerance induction The T cell proliferation assay was used to determine T cell responsiveness to various antigens. After thorough washing, in rodent T cells, little is known about the effects of ECDIcoupled APC on human T cells. The current study focuses 40,000 T cells from a selected T cell clone were cultured in triplicate with 150,000 autologous irradiated PBMC in a on conditions and mechanisms of tolerance induced in vitro by ECDI/antigen-coupled APC on human T h 1 cells specific final volume of 200 µl/well with or without added antigen (10 µl/well) at optimal concentrations. The cultures were for myelin basic protein (MBP), Herpes simplex virus (HSV) or tetanus toxoid (TT), or T h 2 cells specific for the TCR incubated for 3 days at 37°C in 5% CO 2 and were pulsed with 0.5 µCi [ 3 H]thymidine for the last 18 h. The cells were peptide, BV5S2-38-58. The results demonstrate both antigenspecific and antigen-non-specific tolerizing effects of ECDI/ harvested on glass fiber filters and incorporated radioactivity was counted using a liquid scintillation counter, 1205 Betaplantigen-coupled APC on T h 1 but not T h 2 cells that involve a reversible anergy mechanism leading to apoptosis. ate (Wallac, Turku, Finland).
ECDI/antigen-coupled APC Methods
A monocyte-enriched adherent cell population was collected from PBMC after 2 h adherence to the plastic surface of Human subjects tissue culture dishes (Falcon), followed by 5 times washing Blood donors enrolled in this study included eight patients with with RPMI 1640 and removal of the cells using a cell scraper clinically definite relapsing or progressive multiple sclerosis (Costar, Cambridge, MA). The cells obtained were 50-70% (KAH, SDS, TR, JH, ESN, AL, TL and MR) and one healthy CD11b ϩ as determined by flow cytometry (phycoerythrinindividual (EN). These donors were known to respond to MBP, conjugated anti-CD11b; Becton Dickinson, Sunnyvale, CA). HSV, TT or to the BV5S2-38-58 peptide after successful Collected monocytes were coupled with protein as described vaccination in previous studies (23, 24) . previously (11) using water-soluble ECDI (mol. wt 191.7; Calbiochem, La Jolla, CA) that catalyzes the formation of Antigens peptide bonds between free amino and carboxyl groups. The coupling reaction was initiated by preparing 1 ml of cell MBP was extracted and purified using frozen brains supplied by the National Disease Research Interchange (Philadelphia, suspension containing 1 to 5ϫ10 6 monocytes plus antigen in cold saline (MBP, 50-3000 µg/ml; MBP peptides, PA) as described previously (25) . Synthetic peptides corresponding to MBP sequences 8-28 and 149-171 were kind 50 µg/ml; TT peptides, 50 µg/ml; TCR peptides, 50-2000 µg/ml), followed by the addition of 10, 20 or 40 µl of Quantification of secreted cytokines freshly prepared 1 M ECDI (stock solution, 191 mg/ml of cold Cell culture supernatants collected on day 2 were frozen at saline) into 1 ml of the cell suspension to obtain a final -70°C, and later evaluated by ELISA for IL-2, IL-4 and IFN-γ ECDI concentration of 10-40 mM. The cell suspension was as described in kits purchased from PharMingen. Developed incubated for 1 h at 4°C, and the cells were washed 3 times reactions were read on a Kinetic microplate reader (Molecular with culture medium and maintained at 4°C until use.
Devices, Sunnyvale, CA) and quantified using diluted standards.
Co-culture of T cells with ECDI/antigen-coupled APC
Phenotypic analysis by FACScan Antigen-specific T cells were collected during the IL-2 growth phase and after washing 2 times with RPMI 1640 the T cells Monocyte-enriched adherent cells before and after crosswere co-cultured with autologous ECDI/antigen-coupled APC linking to ECDI or coupling with ECDI/antigen were co-stained for 18 h at 37°C in 5% CO 2 at a ratio of 1:1 to 1:2 (T:APC) in in two replicate experiments with mouse anti-human CD11b-a 24-well culture plate (Falcon) with 2-4ϫ10 6 total mixed phycoerythrin (PE) and mouse anti-human B7-1, plus goat cells/well. Cultured cell mixtures were collected and applied anti-mouse IgG-FITC and mouse anti-human B7-2-FITC to a Ficoll gradient, and isolated live cells were washed 3 (PharMingen, San Diego, CA) or mouse anti-human HLA-DRtimes with culture medium, remixed with untreated monocytes FITC (Becton Dickinson, Sunnyvale, CA). Antigen-specific (at the starting ratio) and antigen, and evaluated for prolifera-T cell clones were co-stained with mouse anti-human CD4-tion, cytokine mRNA expression and cytokine secretion. In PE, and FITC-labeled mouse anti-human CD25, CD28, B7-1, some experiments, anti-CD28 antibody (Caltag, Burlingame, B7-2 and HLA-DR (PharMingen). The staining method used CA) or rhIL-2 (R & D Systems) was added to prevent or was similar to that described previously (18) . Two-color fluorreverse tolerance induction. The anti-CD28 antibody was escence was evaluated using a FACScan (Becton Dickinson, either preabsorbed to the wells for 24 h at 4°C at a concentraSunnyvale, CA). tion of 20 µg/ml at pH 8.6, prior to a 3 times wash in culture medium (surface bound) or was added at the indicated Apoptosis detection concentrations in soluble form. Each experimental variable Apoptosis was evaluated in two replicate experiments using was evaluated in two separate experiments.
the Early Apoptosis Detection kit (Kamiya Biochemical, Seattle, WA). After incubation of T cells with autologous Cytokine mRNA expression antigen-coupled APC, viable cells were recovered by RNA was isolated from treated and untreated T cells by a Ficoll-Paque separation, washed, and stained with Annexin modified method (26) . Twenty thousand T cells were placed in V-FITC and propidium iodide according to the manufacturer's a 96-well round-bottomed plate with freshly isolated, irradiated instructions. The cells were analyzed for two-color fluores-PBMC at 2ϫ10 5 /well plus antigen or medium for 48 h at 37°C cence using a FACScan (Becton Dickinson, Sunnyvale, CA). in 5% CO 2 . The cells were harvested and immediately lysed Early apoptotic cells were identified by staining of exposed using the RNA-STAT-60 buffer (Tel-Test, Friendswood, TX).
phosphatidylserine with Annexin V-FITC but not propidium RNA from equal numbers of T cells from each group was iodide, and necrotic cells were identified by Annexin V staining made into cDNA with MLV-RT (Gibco BRL, Frederick, MD), to and uptake of propidium iodide. be used as a template for the cytokine primers. The reaction was run for 34 cycles for granulocyte macrophage colony stimulating factor (GM-CSF) primers, and for 32 cycles for Results IFN-γ, IL-5 and IL-10 primers. To normalize for cell numbers and total RNA used, the human primer pairs for the enzymatic
Antigen-specific inhibition of T h 1 but not T h 2 cells by ECDI/ reporter gene GAPDH were utilized in a 35 µl reaction
antigen cross-linked APC containing 1 µl of cDNA from each sample and run for 27 cycles. The intensity of the GAPDH band signal from each
In our previous studies in rodents, antigen-pulsed APC that were cross-linked with ECDI could induce potent inhibition of sample was used to standardize the amount of cDNA to be used in subsequent reactions. All of the products were T cell responses in vivo and in vitro (17) (18) . To investigate the ability of human ECDI/antigen cross-linked APC to inhibit visualized in ethidium bromide-stained 1.5% agarose gels and displayed as one band of the appropriate mol. wt for T cell responses to specific antigen, we titrated antigen concentration, dose of ECDI and time of the coupling reaction each primer set. The PCR DNA oligonucleotide sequences used for the individual products were as follows: IFN-γ, sense using autologous adherent PBMC. In initial studies, we chose two MBP-specific T h 1 cell clones that were shown previously 5Ј-TCT TGG CTT TTC AGC TCT GCA TC-3Ј, anti-sense 5Ј-GGA TGC TCT TCG ACC TTG AAA CAG-3Ј, 474 bp to produce IFN-γ, but not IL-4, IL-5 or IL-10 (26). Monocyteenriched PBMC were incubated with medium (sham control) product; GM-CSF, sense 5Ј-TGG GAG CAT GTG AAT GCC ATC CAG-3Ј, anti-sense 5Ј-GAC TGG CTC CCA GCA GTC or different concentrations of MBP ranging from 50 to 3000 µg for either 1 or 3 h in the presence of 10 mM ECDI, and AAA GGG-3Ј, 350 bp product; IL-5, sense 5Ј-TAT CCA CTC GGT GTT CAT TAC ACC-3Ј, anti-sense 5Ј-GCT TCT GCA TTT then washed thoroughly to remove free antigen and ECDI. The ECDI/MBP-coupled APC were then incubated with the GAG TTT GCT AGC-3Ј, 510 bp product; IL-10, sense 5Ј-GAC TTT AAG GGT TAC TTG GGT TGC-3Ј, anti-sense 5Ј-CAC MBP-specific T cells for 18 h, washed and then re-stimulated for 3 days with fresh APC plus antigen in a standard prolifera-TGC CTT GCT CTT ATT TTC ACA-3Ј, 201 bp product. tion assay. As is shown in Fig. 1(A) , the degree of inhibition as high as 2000 µg/ml ( Fig. 2A) . Moreover, at ECDI coupling was maximized with increasing doses of antigen used to concentrations ഛ20 mM, there was no antigen-specific inhibipulse the APC. Moreover, a shorter coupling time of 1 h could tion and no inhibition with sham coupled APC (Fig. 2B ). be used with higher antigen doses. In a follow-up experiment, However, coupling with 40 mM ECDI produced a strong nonwe evaluated the effects of ECDI concentration used for specific inhibitory effect that was not further accentuated by cross-linking MBP to the APC. As is shown in Fig. 1(B) , cross-linked antigen. the higher the dose of ECDI used for coupling, the more pronounced the inhibition of response to MBP compared to
Differential donor-dependent non-specific toxicity of ECDI untreated T cells or T cells incubated with sham-coupled
cross-linking on T h 1 cells APC. However, the coupling process itself produced an ECDI concentration-dependent inhibitory effect that was independDuring the course of this study, we noted a variable degree of antigen-non-specific inhibition of MBP-reactive T h 1 cells ent of MBP, resulting in progressively reduced T cell responses after exposure to sham-coupled APC.
after incubation with 'sham' ECDI-cross-linked APC versus untreated APC. Overall, there were striking differences among Similar experiments were carried out to titrate coupling conditions using a BV5S2-38-58-specific T h 2 cell clone that donors in the degree of non-specific inhibition, ranging from about 20% in donor JH to Ͼ90% in donor ESN, with an was shown previously to produce IL-4 and IL-10, but not IFN-γ (26) . Unlike the results using T h 1 clones, there was no average inhibition of 57 Ϯ 25% (Table 1) . In contrast, nonspecific inhibition of TCR peptide-specific T h 2 cell responses inhibition when ECDI/antigen-coupled APC were incubated with the T h 2 clone, even at coupling antigen concentrations (average inhibition of 3 Ϯ 3%) did not occur after incubation demonstrate that in addition to antigen-non-specific effects, ECDI/antigen-coupled APC induced T cell inhibition that was antigen-specific. of ECDI/antigen tolerization on cytokine mRNA expression and cytokine secretion. As is shown in Fig. 4(A) , message for when BV5S2-specific T cells were first co-cultured with ECDI/ BV5S2-38-58 peptide-coupled APC and then re-stimulated with the same peptide plus untreated APC (Fig. 4B ). These with 'sham' ECDI-cross-linked APC versus untreated APC data indicate that pre-exposure to ECDI/antigen-coupled APC (Table 1) .
inhibited message production of T h 1 but not T h 2 cells, in accordance with proliferation data. In a separate experiment, Antigen-specific T cell inhibition by ECDI/antigen-coupled secreted cytokines were quantified by ELISA in culture super-APC natants from an antigen-activated MBP-specific T h 1 cell clone In addition to the antigen-non-specific component of ECDI/ after pretreatment with ECDI-or ECDI/MBP-coupled APC, or antigen-coupled APC described above, we sought to critically no pretreatment. As is shown in Fig. 5 , pretreatment with evaluate the specificity of antigen-induced tolerance. Thus, ECDI-coupled APC markedly reduced secreted IL-2 and IFN-γ three different antigen-specific T cell clones were incubated levels, and pretreatment with ECDI/antigen-coupled APC with relevant or control ECDI/antigen-coupled autologous essentially abrogated production of both cytokines. As APC and then re-stimulated with relevant antigen (Fig. 3) . A expected for this T h 1 clone, IL-4 levels were undetectable TT-specific T cell clone selected from donor ESN, specifically before and after tolerization. responsive to TT and the TT peptide T6, but not to any other Induction of apoptosis by ECDI/antigen-coupled APC of five non-overlapping TT peptides, was significantly inhibited with ECDI/T6-but not ECDI/T1-coupled APC. Similarly, an
One result of TCR ligation in the absence of co-stimulation is antigen-induced cell death. Thus, after treatment with ECDI/ MBP-specific clone from donor JH was significantly inhibited the mechanism of tolerance induced by ECDI/antigencoupled APC involved both apoptosis and anergy.
Expression of cell surface markers on APC and T cells
The apparent lack of functional co-stimulation suggested that the ECDI/antigen-coupled APC or responder T cells might have changes in the expression of contributing cell-surface proteins. Thus, phenotypic changes were evaluated in monocyte-enriched adherent cells after ECDI-or ECDI/antigencoupling, and in antigen-tolerized T cells. As is shown in Table 2 , the expression of B7-1, B7-2 or HLA-DR on CD11b ϩ APC did not change as a result of ECDI/saline or ECDI/ antigen cross-linking. However, several phenotypic changes were apparent in tolerized CD4 ϩ T h 1 cells. IL-2R (CD25) (Table 3 ). In contrast, non-tolerized T cells had strongly compared to control cultures. IL-4 levels were Ͻ10 pg/ml in all culture enhanced expression of IL-2R after re-stimulation. Additionsupernatants.
ally, pretreatment with either ECDI/antigen cross-linked APC or ECDI-APC followed by re-stimulation with antigen plus APC induced an increase in expression of HLA-DR, and a decrease in expression of CD28, B7-2 and possibly B7-1 (Table 3) . antigen-coupled autologous APC, T cells were evaluated for induction of early apoptosis and necrosis, using Annexin V and propidium iodide staining and FACS analysis. As is shown Discussion in Fig. 6 , T h 1 cells committed to apoptosis/necrosis increased from a background of 4 to 27% 48 h after exposure to APC The observations described above provide unique evidence demonstrating that tolerization with ECDI/antigen-coupled cross-linked with ECDI/saline and to 36% 48 h after the T cells encountered antigen-coupled APC. In contrast, T h 2 APC differentially affects T h 1 but not T h 2 cells. Tolerization was a multi-step process that occurred when T h 1 cells were cells were relatively resistant to apoptosis/necrosis induction, increasing from a background of 5% to only 6 and 10% activated in the absence of co-stimulation or ligation of IL-2R, and involved (i) an antigen-independent interaction, respectively 48 h after exposure to ECDI-APC or ECDI/ antigen-APC (Fig. 6) .
presumably between TCR and MHC but possibly involving other APC or T cell surface molecules (e.g. CD4), that induced Effects of co-activation factors on prevention and reversal of partial signaling and resulted in moderate changes in T cell ECDI/antigen-coupled APC mediated tolerance phenotype, proliferation response and cytokine secretion; and (ii) an antigen-dependent interaction with the TCR that induced Our previous studies in rodents demonstrated that T cell inhibition induced by ECDI/antigen-coupled APC could be more extensive signaling and resulted in pronounced changes that further potentiated the inhibitory effect. Antigen-specific reversed by IL-2, thereby suggesting an anergy mechanism induced by engagement of the MHC-antigen complex in the inhibition was dependent upon the concentration of antigen and ECDI used to cross-link APC, and the time period of the absence of functional co-stimulation. To determine if inhibition of human T h 1 cells involved a similar mechanism, co-activation coupling reaction. The inhibitory mechanism involved both apoptosis and anergy. Antigen-specific inhibition could be factors were added to the cultures either during or after the tolerization process to prevent or reverse tolerance induction.
prevented during the tolerization step by the addition of IL-2, surface-bound anti-CD28 mAb, or untreated APC. Moreover, As is shown in Fig. 7(A) , the presence of IL-2, surface-bound but not soluble anti-CD28 mAb or untreated autologous APC the tolerizing effect of exposure to ECDI/antigen-coupled APC on T h 1 cells could be overcome during the re-stimulation step prevented the inhibition of T h 1 proliferation responses by ECDI-and ECDI/antigen-coupled autologous APC. To evaluby either IL-2 or anti-CD28 antibody, suggesting a reversible anergy mechanism for those cells not committed to apoptosis. ate the ability of IL-2 or anti-CD28 antibody to reverse tolerance, T cells previously tolerized with ECDI/MBP-coupled
In contrast to T h 1 cells, T h 2 cells were resistant to tolerization with ECDI/antigen-coupled APC, showing neither antigen-APC were re-stimulated with MBP plus fresh APC with or without further addition of surface-bound anti-CD28 mAb or specific nor antigen-non-specific inhibition after re-stimulation with untreated APC plus antigen, and relative resistance to different concentrations of soluble anti-CD28 mAb or IL-2. As is shown in Fig. 7(B) , 20 ng/ml IL-2 completely reversed apoptosis. T cell activation usually requires at least two signals, one antigen-induced tolerance, whereas bound or soluble anti-CD28 mAb restored approximately two-thirds of the T cell delivered through the TCR by the MHC/antigen complex on APC and a second co-stimulatory signal, e.g. through the response. Moreover, addition of IL-2 24 h after exposure to ECDI/antigen-coupled APC prevented further induction of CD28 molecule on the T cell that interacts with the B7 family on APC (27-28) or the T cell OX-40 receptor that interacts apoptosis (Fig. 6) . Taken together, these data indicate that 6 . Enhanced susceptibility of T h 1 cells to apoptosis induced by ECDI-coupled APC. T h 1 or T h 2 cells were incubated for 18 h with untreated, ECDI/saline-coupled or ECDI/antigen-coupled APC, washed, and re-stimulated for 24 or 48 h with antigen ϩ APC prior to apoptosis detection. Coupling was carried out with 20 mM ECDI. Some 24 h cultured T h 1 cells were further incubated with 10 ng/ml IL-2 for 72 h prior to apoptosis detection. Apoptosis was evaluated by FACS after staining with Annexin V-FITC mAb and propidium iodide as described in Methods.
with the APC OX-40 ligand (29) . Activation induces expression γ chain are present (30) , the T cell may persist for weeks or months. However, with depletion of such life-sustaining facof the IL-2R, and as long as IL-2 or other survival factors such as IL-4, IL-7 or IL-15 that can bind to the IL-2R common tors, most T cells undergo AICD/AIA. It is now well established (Table 2) concentrations for 3 days and assessed for proliferation responses (100% response ϭ 60,000 net c.p.m.).
or fluorescence intensity of these molecules (not shown), indicating that conformational determinants recognized by specific mAb remained intact. However, both MHC/antigen and B7 molecules might be functionally altered by ECDI, due possibly to their decreased flexibility and mobility on the APC that signaling through the T cell receptor in the absence of co-stimulation induces T cell anergy (6). Blockade of the surface. Successful T cell activation appears to require crosslinking, aggregation and capping of the TCR, and it seems CD28-B-7 or OX-40R-OX-40L interaction inhibits production of IL-2, and is sufficient to produce anergy (29, 31) and plausible that an inability of stimulatory and co-stimulatory molecules on the APC to migrate to a focal area of cell surface eventually apoptosis in a majority of T cells unless IL-2 is available from another source.
interaction with the T cell might produce suboptimal or disjointed signaling. It is now apparent that there are important differences in signaling pathways required for activation of T h 1 versus T h 2 Given these considerations, it is important to consider how in the absence of specific antigen, ECDI-cross-linked APC similar inhibitory properties. To this end, we have recently produced a soluble, single-chain TCR ligand, comprised of could induce such strong inhibition of T h 1 but not T h 2 cells. One possibility is that the ECDI cross-linking somehow favors the β 1 and α 1 MHC class II domains with or without bound peptide antigen (43) . This genetically engineered molecule interaction of B-7 molecules with CTLA-4 rather than CD28. Cross-linking CTLA-4 but not CD28 on previously activated can specifically bind to antigen-specific T cells, has potent and selective inhibitory properties in vivo, and appears to T cells can induce anergy/apoptosis (40) in the absence of IL-12 (41). However, for ECDI-coupled APC to induce inhibition deliver all or part of the antigen-specific signal through the TCR without coordinate co-stimulation of CD28, CTLA-4 or and apoptosis, there would still be a TCR signaling requirement. Although specific peptide antigen was absent, it is CD4. Such TCR ligands will be invaluable for dissecting the exact molecular interactions that drive the tolerization process, conceivable that partial TCR engagement by cross-linked MHC II could provide enough of a signal to the TCR to trigger especially when studied in combination with various costimulatory agents (ligands or mAb), and represent a new CTLA-4-induced apoptosis. Incubation with ECDI-coupled APC clearly induced changes in T h 1 cells, including enhanced class of reagents potentially useful for detection and elimination of autoreactive or inflammatory T h 1 cells. expression of HLA-DR, reduced expression of IL-2R, CD28 and B-7, and reduced secretion of IL-2 and IFN-γ. Because the antigen-non-specific inhibition of T h 1 cells could be Acknowledgements negated by both IL-2 and surface-bound anti-CD28 mAb, it is as has been reported during antigen presentation by T cells the antigen-independent inhibitory effects and the need to 
